These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12667482)

  • 1. A role for apolipoprotein(a) in protection of the low-density lipoprotein component of lipoprotein(a) from copper-mediated oxidation.
    Hill BC; Becker L; Anand V; Kusmierczyk A; Marcovina SM; Rahman MN; Gabel BR; Jia Z; Boffa MB; Koschinsky ML
    Arch Biochem Biophys; 2003 Apr; 412(2):186-95. PubMed ID: 12667482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposed mechanisms for binding of apo[a] kringle type 9 to apo B-100 in human lipoprotein[a].
    Guevara J; Spurlino J; Jan AY; Yang CY; Tulinsky A; Prasad BV; Gaubatz JW; Morrisett JD
    Biophys J; 1993 Mar; 64(3):686-700. PubMed ID: 8386013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
    Gabel BR; Koschinsky ML
    Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the mechanism of lipoprotein(a) assembly.
    Koschinsky ML; Marcovina SM; May LF; Gabel BR
    Clin Genet; 1997 Nov; 52(5):338-46. PubMed ID: 9520124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition of the structural elements in plasminogen required for high-affinity binding to apolipoprotein(a): a study utilizing surface plasmon resonance.
    Hancock MA; Spencer CA; Koschinsky ML
    Biochemistry; 2004 Sep; 43(38):12237-48. PubMed ID: 15379562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of lipoprotein(a) assembly: a study of wild-type and mutant apolipoprotein(a) phenotypes isolated from human and rhesus monkey lipoprotein(a) under mild reductive conditions.
    Edelstein C; Mandala M; Pfaffinger D; Scanu AM
    Biochemistry; 1995 Dec; 34(50):16483-92. PubMed ID: 8845377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein(a) binds to low-density lipoprotein at two distant sites in lipoprotein(a).
    Xu S
    Biochemistry; 1998 Jun; 37(26):9284-94. PubMed ID: 9649309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidation of apolipoprotein(a) inhibits kringle-associated lysine binding: the loss of intrinsic protein fluorescence suggests a role for tryptophan residues in the lysine binding site.
    Hermann A; Laws WR; Harpel PC
    Protein Sci; 1997 Nov; 6(11):2324-35. PubMed ID: 9385634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of a recombinant form of apolipoprotein[a] with human fibroblasts and with the human hepatoma cell line HepG2.
    Tam SP; Zhang X; Koschinsky ML
    J Lipid Res; 1996 Mar; 37(3):518-33. PubMed ID: 8728315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation.
    Becker L; Cook PM; Koschinsky ML
    Biochemistry; 2004 Aug; 43(31):9978-88. PubMed ID: 15287725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.
    Kang C; Dominguez M; Loyau S; Miyata T; Durlach V; Anglés-Cano E
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1232-8. PubMed ID: 12117743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The susceptibility of lipoprotein(a) to copper oxidation is correlated with the susceptibility of autologous low density lipoprotein to oxidation.
    Nakajima K; Yamashita T; Kusuhara M; Yonemura A; Ito T; Higashi K; Ayaori M; Ohmori R; Nakamura H; Ohsuzu F
    Clin Biochem; 2003 Mar; 36(2):113-20. PubMed ID: 12633760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.
    Anglés-Cano E; Rojas G
    Biol Chem; 2002 Jan; 383(1):93-9. PubMed ID: 11928826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct evidence for apo B-100-mediated copper reduction: studies with purified apo B-100 and detection of tryptophanyl radicals.
    Batthyány C; Santos CX; Botti H; Cerveñansky C; Radi R; Augusto O; Rubbo H
    Arch Biochem Biophys; 2000 Dec; 384(2):335-40. PubMed ID: 11368321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules.
    Xue S; Green MA; LoGrasso PV; Boettcher BR; Madison EL; Curtiss LK; Miles LA
    Thromb Haemost; 1999 Mar; 81(3):428-35. PubMed ID: 10102473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB Secretion.
    Youssef A; Clark JR; Marcovina SM; Boffa MB; Koschinsky ML
    Arterioscler Thromb Vasc Biol; 2022 Mar; 42(3):289-304. PubMed ID: 35045727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear magnetic resonance (NMR) solution structure, dynamics, and binding properties of the kringle IV type 8 module of apolipoprotein(a).
    Chitayat S; Kanelis V; Koschinsky ML; Smith SP
    Biochemistry; 2007 Feb; 46(7):1732-42. PubMed ID: 17263558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the basis of lipoprotein [a] lysine-binding heterogeneity.
    Xia J; May LF; Koschinsky ML
    J Lipid Res; 2000 Oct; 41(10):1578-84. PubMed ID: 11013299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of in vitro low-density lipoprotein oxidation by an albumin-containing Lp A-I subfraction.
    Decossin C; Tailleux A; Fruchart JC; Fiévet C
    Biochim Biophys Acta; 1995 Mar; 1255(1):31-8. PubMed ID: 7893735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
    Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
    Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.